Gene · 6080
Papers2,015
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,015
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Simian Adenovirus Associating with Human Adeno-virus Species G Isolated from Long-Tailed Macaque Feces. | Viruses | 2023 | 37376670 | PubTator, text mining | PubMed |
| Analyzing the Geometry and Dynamics of Viral Structures: A Review of Computational Approaches Based on Alpha Shape Theory, Normal Mode Analysis, and Poisson-Boltzmann Theories. | Viruses | 2023 | 37376665 | PubTator, text mining | PubMed |
| In Vitro and In Vivo Efficacy of a Stroma-Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of Cancer. | Int J Mol Sci | 2023 | 37373140 | PubTator, text mining | PubMed |
| Updates in Glioblastoma Immunotherapy: An Overview of the Current Clinical and Translational Scenario. | Biomedicines | 2023 | 37371615 | PubTator, text mining | PubMed |
| SNORD6 promotes cervical cancer progression by accelerating E6-mediated p53 degradation. | Cell Death Discov | 2023 | 37369687 | PubTator, text mining | PubMed |
| Adenovirus as a Vector and Oncolytic Virus. | Curr Issues Mol Biol | 2023 | 37367056 | PubTator, text mining | PubMed |
| Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus. | Eur J Med Chem | 2023 | 37364511 | PubTator, text mining | PubMed |
| Improving cell and gene therapy safety and performance using next-generation Nanoplasmid vectors. | Mol Ther Nucleic Acids | 2023 | 37346980 | PubTator, text mining | PubMed |
| Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. | World J Gastrointest Pathophysiol | 2023 | 37304923 | PubTator, text mining | PubMed |
| Efficacy and adverse reaction management of oncolytic viral intervention combined with chemotherapy in patients with liver metastasis of gastrointestinal malignancy. | Front Oncol | 2023 | 37197423 | PubTator, text mining | PubMed |
| Recent advances in oncolytic virus therapy for hepatocellular carcinoma. | Front Oncol | 2023 | 37182136 | PubTator, text mining | PubMed |
| Apobec3A Deamination Functions Are Involved in Antagonizing Efficient Human Adenovirus Replication and Gene Expression. | mBio | 2023 | 37154747 | PubTator, text mining | PubMed |
| The interactions between PML nuclear bodies and small and medium size DNA viruses. | Virol J | 2023 | 37127643 | PubTator, text mining | PubMed |
| Non-structural genes of novel lemur adenoviruses reveal codivergence of virus and host. | Virus Evol | 2023 | 37091898 | PubTator, text mining | PubMed |
| An in silico approach for prediction of B cell and T cell epitope candidates against Chikungunya virus. | Immunol Med | 2023 | 37078425 | PubTator, text mining | PubMed |
| Engineering Oncolytic Coxsackievirus A21 with Small Transgenes and Enabling Cell-Mediated Virus Delivery by Integrating Viral cDNA into the Genome. | J Virol | 2023 | 37070982 | PubTator, text mining | PubMed |
| Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health. | Transl Med Commun | 2023 | 37065938 | PubTator, text mining | PubMed |
| The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions. | Int J Mol Sci | 2023 | 37047452 | PubTator, text mining | PubMed |
| Oncolytic virotherapy: basic principles, recent advances and future directions. | Signal Transduct Target Ther | 2023 | 37041165 | PubTator, text mining | PubMed |
| Oncolytic adenoviruses and the treatment of pancreatic cancer: a review of clinical trials. | J Cancer Res Clin Oncol | 2023 | 37031291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6080/papers?page=5